Efficacy and Safety of Inhaled Carbon Monoxide during Pulmonary Inflammation in Mice
Michael R. Wilson, Kieran P. O'Dea, Anthony D. Dorr et al. · 2010
Read Efficacy and Safety of Inhaled Carbon Monoxide during Pulmonary Inflammation in Mice by Michael R. Wilson, Kieran P. O'Dea, Anthony D. Dorr et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011565.txt.
Description
Michael Wilson and co-authors tested in 2010 the paradox of carbon monoxide as a lung treatment. The gas is famous as a silent killer in faulty heaters, yet the body makes tiny amounts of it naturally, and small doses calm inflammation in animal studies. The team gave inhaled carbon monoxide to mice with pulmonary inflammation and measured both benefit and safety in the same experiment.
A therapy that is poison at one dose and medicine at another lives or dies on its margin, so testing efficacy and safety together is the honest design. Their results inform whether the gas can soothe injured lungs without harming the animal that breathes it. Inhaled delivery is attractive because the lung, the target, receives the dose first. The study is a careful step in judging a provocative idea, neither dismissing it for its reputation nor trusting it for its promise.
Catalog record
| CREATOR | Michael R. Wilson, Kieran P. O'Dea, Anthony D. Dorr et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011565